HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.

AuthorsTimothy Lax, Don S Dizon, Michael Birrer, Aidan Long, Marcela Del Carmen, Annekathryn Goodman, Carolyn Krasner, Richard T Penson, Whitfield Growdon, Carlos A Camargo Jr, Aleena Banerji
JournalThe journal of allergy and clinical immunology. In practice (J Allergy Clin Immunol Pract) 2017 Jan - Feb Vol. 5 Issue 1 Pg. 177-178 ISSN: 2213-2201 [Electronic] United States
PMID27641482 (Publication Type: Letter)
Chemical References
  • Platinum Compounds
  • Carboplatin
Topics
  • Administration, Intravenous
  • Aged
  • Aged, 80 and over
  • Carboplatin (therapeutic use)
  • Cystadenoma, Serous (drug therapy, epidemiology)
  • Drug Hypersensitivity (epidemiology)
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Ovarian Neoplasms (drug therapy, epidemiology)
  • Platinum Compounds (therapeutic use)
  • Remission Induction
  • Retrospective Studies
  • Time Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: